Sinopharm
1099.HK
2,19 €
Share price
-0.22%
Change (1 day)
-9.13%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
EPS for Sinopharm (1099.HK)
EPS in 2022: 0,37 €
According to Sinopharm's latest financial reports the company's current EPS (TTM) is 0,37 €. In 2022 the company made an earnings per share (EPS) of 0,37 € an increase over its 2021 EPS that were of 0,36 €.
EPS history for Sinopharm from 2006 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | 0,37 € | 1.3% |
| 2021 | 0,36 € | 10.33% |
| 2020 | 0,33 € | 17.26% |
| 2019 | 0,28 € | 5.44% |
| 2018 | 0,27 € | -0.87% |
| 2017 | 0,27 € | 19.44% |
| 2016 | 0,22 € | 15.3% |
| 2015 | 0,19 € | 17.06% |
| 2014 | 0,17 € | 21.9% |
| 2013 | 0,14 € | 11.82% |
| 2012 | 0,12 € | 25.24% |
| 2011 | 0,09722 € | 31.02% |
| 2010 | 0,07421 € | 3.3% |
| 2009 | 0,07184 € | 46.85% |
| 2008 | 0,04892 € | 67.57% |
| 2007 | 0,02919 € | 310.24% |
| 2006 | 0,007116 € |